Approved alternatives have clearer prescribing information
Potential Benefits for Cardiovascular and Liver Health Phase 2 data showed reductions in liver fat content on MRI, relevant to MASLD, but dedicated cardiovascular outcomes trials have not yet been completed and cardiovascular benefits remain unconfirmed
She applies the WegovySavings card, reducing her cost to $25 per month for the first year
Long-term data on semaglutide now extends beyond five years for diabetes indications and approximately three years for weight management, with ongoing extension studies continuing to accumulate evidence
(5.1) Indications and Usage for Janumet XR JANUMET XR is a combination of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Cardiovasc Psychiatry Neurol